L’Oréal Group has acquired a majority stake in British skin-care brand Medik8. European private equity firm, Inflexion, remains a minority shareholder, and brand founder Elliot Isaacs will stay on the board. While the company has not shared the financial deal, WWD reported the acquisition was valued at around €1 billion. “We share a strong belief in Medik8’s global potential and are excited to embark on this journey together, to build a powerful and impactful brand presence worldwide,” Cyril Chapuy, president of L’Oréal Luxe, said in a statement.L’Oréal Groupe to Acquire S
L’Oréal Groupe to Acquire a Majority Stake in Medik8 [press release]
For more of the latest in litigation, regulation, deals and financial services trends, sign up for Finance Docket, a partnership between Breaking Media publications Above the Law and Dealbreaker.
